Type
Merger/Acquisition
Country
France
Region
Bassin Parisien; Basse-Normandie; Calvados
Location of affected unit(s)
Hérouville-Saint-Clair
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

100 jobs
Number of planned job losses
Job loss
Announcement Date
2 February 2011
Employment effect (start)
1 January 2012
Foreseen end date

Description

On 5 October 2011, unions protested to put pressure on the management of US pharmaceutical group Schering-Plough which had announced, in February, a redundancy plan at their site in Hérouville-Saint-Clair (428 employees).

Some 100 jobs are expected to be cut at the site. However the management decided to freeze the restructuring until 31 December 2011 and, meanwhile, find a company to take over the pharmaceutical activities of the site.

CGT union representative Joël Boyer said management has indicated that due to lack of buyer for the pharmaceutical part of the site, production will be transferred to Germany and the Netherlands. The restructuring plan is a consequence of the process of merging with fellow US pharmaceutical company Merck. When the merger was announced, Merck indicated that 15% of the global workforce of the two groups would be cut.


Sources

Citation

Eurofound (2011), Schering-Plough, Merger/Acquisition in France, factsheet number 72542, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/72542.